MARKET

LGND

LGND

Ligand Pharma
NASDAQ
78.70
-0.65
-0.82%
After Hours: 77.00 -1.7 -2.16% 17:31 03/01 EST
OPEN
80.05
PREV CLOSE
79.35
HIGH
80.94
LOW
77.07
VOLUME
173.04K
TURNOVER
0
52 WEEK HIGH
94.57
52 WEEK LOW
49.24
MARKET CAP
1.37B
P/E (TTM)
94.04
1D
5D
1M
3M
1Y
5Y
Ligand Pharmaceuticals Inc’s New Competition Risk – A Cause for Worry?
TipRanks · 20h ago
HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target
Benzinga · 2d ago
Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), Springworks Therapeutics (SWTX)
TipRanks · 2d ago
Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges
NASDAQ · 3d ago
Analysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC), Ligand Pharma (LGND) and Alphatec Holdings (ATEC)
TipRanks · 3d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ligand Pharma (LGND), Agilent (A) and Eli Lilly & Co (LLY)
Analysts maintain Buy and Sell ratings on Ligand Pharma, Agilent and Eli Lilly & Co. The Healthcare sector has received a lot of coverage today as analysts weigh in on the stocks. Lig and Pharma received a Buy rating and a $110.00 price target from Barclays yesterday.
TipRanks · 3d ago
Why Is Ligand Pharmaceuticals Stock Trading Higher Today?
Ligand Pharmaceuticals Incorporated reported fourth-quarter 2023 sales of $28.1 million. The company beat the consensus estimate of $25.72 million. Ligand reaffirms the fiscal year 2024 EPS guidance of $4.25-$4.75.
Benzinga · 4d ago
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Helix Energy Solutions Group, Inc. Shares dipped 11% to $9.13 on Tuesday. The company posted weak earnings of 6 cents per share. Janux Therapeutics shares jumped 145% after the company announced updated clinical data for both of its clinical programs. Other stocks moving in Tuesday's mid-day session included Viking Therapeutic and Presto Automation.
Benzinga · 4d ago
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company. The Company is focused on acquiring or funding programs and technologies that pharmaceutical companies use to discover and develop medicines. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Its Pelican Expression technology is a scalable platform for recombinant protein production, and is especially suited for complex, large-scale protein production. Its products include Kyprolis, Teriparatide, Evomela, Rylaze, Nexterone, Pneumosil, Vaxneuvance, and others. Kyprolis is formulated with its Captisol technology. Teriparatide Injection is a drug indicated for use including the treatment of osteoporosis in certain patients at high risk for fracture. Evomela is a Captisol-enabled melphalan IV formulation. It also owns berdazimer gel and all the assets related to the NITRICIL technology platform, and rights to Sitavig program.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.